Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 547 pembrolizumab 381 Radiotherapy 361 Bevacizumab 359 Carboplatin 351 Rituximab 315 Cisplatin 300 Gemcitabine 297 Paclitaxel 288 Docetaxel 271 Dexamethasone 271 fludarabine phosphate 240 Doxorubicin 231 Nivolumab 219 Etoposide 208 Cytarabine 202 Lenalidomide 200 fludarabine 191 Oxaliplatin 191 Fluorouracil 190 Melphalan 189 Filgrastim 188 Capecitabine 175 Calcium Dobesilate 172 Radiosurgery 167 Erlotinib Hydrochloride 167 Methotrexate 162 Bortezomib 162 Granulocyte Colony-Stimulating Factor 153 Whole-Body Irradiation 143

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Has results × Tissue Array Analysis × Clear all

NCT02236546 2017-04-13

FDG-PET in Advanced Melanoma

Vanderbilt-Ingram Cancer Center

Phase NA Terminated

3 enrolled 4 charts

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡